• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The role of spleen-derived IL-10 and portal GLP-1 levels in the prevention of obesity-induced dementia

Research Project

Project/Area Number 15K01721
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Applied health science
Research InstitutionOita University

Principal Investigator

Gotoh Koro  大分大学, 医学部, 助教 (10457624)

Co-Investigator(Kenkyū-buntansha) 正木 孝幸  大分大学, 医学部, 講師 (00423715)
植田 聡  大分大学, 医学部, 助教 (00624511)
柴田 洋孝  大分大学, 医学部, 教授 (20245484)
加隈 哲也  大分大学, 保健管理センター, 准教授 (80343359)
Project Period (FY) 2015-04-01 – 2018-03-31
Project Status Completed (Fiscal Year 2017)
Budget Amount *help
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2017: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2016: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2015: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
Keywords肥満 / GLP-1 / BDNF / アルツハイマー型認知症 / 脾臓 / IL-10 / 小腸 / 脳内BDNF / 炎症
Outline of Final Research Achievements

Obesity induces systemic low-grade chronic inflammation. Dementia is deeply related with amyloid deposition although the mechanism is uncertain. BDNF is an important factor to prevent neuronal death which occurs in Alzheimer's disease. The aim of this study is to clarify that the elevation of GLP-1 secretion improves obesity-induced decrease of BDNF expression in the brain. Splenectomy (SPX) promotes obesity-induced decrease of GLP-1 expression and increase of DPP-4 activity in small intestine. Chronic IL-10 treatment attenuated these SPX-induced alterations. Moreover, SPX also worsened obesity-induced reduction of BDNF expression in the brain, and IL-10 treatment recovered this expression. There was no difference among all groups in amyloid deposits in the brain. In addition, we clarified that the administration of a DPP-4 inhibitor elevated BDNF expression in the brain. Thus, the GLP-1 might induce BDNF expression in the brain and be effective to prevent the development of dementia.

Report

(4 results)
  • 2017 Annual Research Report   Final Research Report ( PDF )
  • 2016 Research-status Report
  • 2015 Research-status Report
  • Research Products

    (3 results)

All 2017

All Journal Article (1 results) (of which Peer Reviewed: 1 results,  Open Access: 1 results) Presentation (2 results)

  • [Journal Article] Glucagon-like peptide-1 reduces pancreatic β-cell mass through hypothalamic neural pathways in high-fat diet-induced obese rats.2017

    • Author(s)
      Ando H, Gotoh K, Fujiwara K, Anai M, Chiba S, Masaki T, Kakuma T, Shibata H.
    • Journal Title

      Sci Rep.

      Volume: 7 Pages: 5578-5578

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Open Access
  • [Presentation] 肥満による代償性膵島過形成に対するGLP-1の中枢神経を介した改善作用2017

    • Author(s)
      後藤孔郎
    • Organizer
      日本肥満学会
    • Related Report
      2017 Annual Research Report
  • [Presentation] 肥満モデル動物に対するテネリグリプチンの脳保護効果2017

    • Author(s)
      後藤孔郎
    • Organizer
      日本糖尿病学会
    • Related Report
      2017 Annual Research Report

URL: 

Published: 2015-04-16   Modified: 2019-03-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi